FDA – Page 3 – Physicence.com

A common anti-anxiety pill taken by 16 million Americans isn’t very effective and its effectiveness has been greatly exaggerated, according to a Harvard analysis.

October 24, 2023 by Paul

Xanax, also known as alprazolam, was approved by the FDA in 1981 and belongs to the benzodiazepine class, a group of depressant medications used to relieve anxiety.

It’s known to be addictive, harmful to the body, and carries the risk of overdose — and now scientists say Xanax might not even be that effective. Researchers from Harvard University and Oregon Health & Science University re-examined trials and studies investigating the effectiveness of Xanax in treating panic disorder. They found several examples of …

CVS to withdraw cold medications after FDA scientists say they don’t work

October 23, 2023 by Paul

The era of over-the-counter cold medications is coming to an end. Major retail chain CVS announced this month that it would remove certain cold and cough products containing oral phenylephrine from its shelves. The Food and Drug Administration may soon push for the ingredient to be removed en masse from these over-the-counter products, following a …

CVS removes decongestant from shelves after FDA panel says it is ineffective

October 20, 2023 by Paul

CVS Health is considering removing a common type of decongestant from shelves after a U.S. Food and Drug Administration advisory committee said it was ineffective earlier this year. The products contain the oral formulation of phenylephrine (PE), which is found in several over-the-counter (OTC) medications. Although PE has been used as a decongestant for nearly …

Counterfeit versions of the “next Ozempic” retatrutide are being peddled by the Chinese site GorillaHealing.com, even though the real version will not be approved until at least 2026.

October 20, 2023 by Paul

Counterfeit versions of Eli Lilly's retatrutide, hailed as potential 'new Ozempic,' sold directly to US consumers

Counterfeit versions of Eli Lilly’s retatrutide, hailed as a potential “new Ozempic,” are being sold directly to U.S. consumers through Chinese websites, although regulatory approval remains years away. Hundreds of marketers are offering the new drug to buyers in the United States through websites such as Made-in-China.com and GorillaHealing.com, the Wall Street Journal reports. Some …

UCB Obtains FDA Approval for Treatment of Plaque Psoriasis After Regulatory Setbacks | BioSpace

October 19, 2023 by Paul

Pictured: A woman scratches skin lesions on her elbow/iStock, helivideo The FDA on Wednesday approved UCB’s bimekizumab for the treatment of adults with moderate to severe plaque psoriasis. The treatment will be sold under the Bimzelx brand. Bimzelx is a humanized IgG1 monoclonal antibody that acts by targeting IL-17A and IL-17F, two central players in …

FDA Approves Pilocarpine Hydrochloride Ophthalmic Solution to Treat Presbyopia

October 18, 2023 by Paul

Pilocarpine hydrochloride ophthalmic solution 0.4% (Qlosi, Orasis Pharmaceuticals) has received FDA approval for the treatment of presbyopia in adults. Presbyopia is the loss of the ability to focus on nearby objects and is caused by the natural aging process. A press release from Orasis states that 128 million people in the United States are affected …

FDA Approves Tenapanor for Treatment of Chronic Kidney Disease

October 18, 2023 by Paul

The FDA has approved tenapanor (Xphozah; Ardelyx, Inc.), making it the first and only phosphate absorption inhibitor approved to reduce serum phosphorus in adults with chronic kidney disease (CKD) who are on dialysis as adjunctive therapy in patients who either do not respond to phosphate binders or who are intolerant to any dose of phosphate …

FDA approves Qlosi eye drops for treatment of presbyopia

October 18, 2023 by Paul

October 18, 2023 1 minute reading Add a subject to email alerts Receive an email when new articles are published on Please provide your email address to receive an email when new articles are posted to . ” data-action=”subscribe”> Subscribe We have not been able to process your request. Please try …

New IBD and ulcerative colitis drug gets FDA approval: ‘astonishing results’

October 16, 2023 by Paul

A new drug intended to treat a type of inflammatory bowel disease (IBD) has received the green light from the Food and Drug Administration. The FDA on Friday approved Pfizer’s etrasimod, branded as Velsipity, to treat adults with a chronic digestive disorder known as ulcerative colitis (UC). The oral pill, taken once a day, was …

Karuna plans to more than double staff if schizophrenia drug approved – The Boston Globe

October 12, 2023 by Paul

I don’t want to give the impression that we are too confident, he said. But I think we were confident in the development plan that we executed and were preparing to launch KarXT in the second half of next year. KarXT uses a different mechanism than other antipsychotic medications on the market. Medications such as …